首頁 > 市場調查報告書 > 醫療設備

生技設備基因治療學和RNAi 基因療法

病毒清除市場規模、佔有率和成長分析（按類型、應用、最終用戶、方法和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1899589

病毒清除市場規模、佔有率和成長分析（按類型、應用、最終用戶、方法和地區分類）－2026-2033年產業預測

Viral Clearance Market Size, Share, and Growth Analysis, By Type (Viral Removal Method, Viral Inactivation Method), By Application (Recombinant Proteins, Blood), By End User, By Method, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 260 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，病毒清除市場規模將達到 6,218.3 億美元，到 2025 年將成長至 7,219.5 億美元，到 2033 年將成長至 2,3832.1 億美元，在預測期（2026-2033 年）內複合年成長率為 16.1%。

病毒清除對於確保單株抗體、重組蛋白、糖蛋白和醫療設備等產品的安全性至關重要，因為這些產品極易受到病毒和其他雜質的污染。病毒、細菌和真菌的威脅會損害細胞培養、原料和生物加工等各個環節。因此，市場對強而有力的病毒安全通訊協定的需求日益成長，以降低這些風險。製藥和生物技術領域投資的成長以及疫苗和生物製藥需求的增加，是推動病毒清除市場發展的主要動力。隨著產業致力於提高產品安全性，有效病毒清除方法的實施正成為成功生產流程的關鍵因素，並推動該領域的創新和成長。

病毒清除市場促進因素

全球病毒清除市場的主要促進因素是，在生物製藥日益關注生物製劑傳播病毒風險的背景下，對安全有效的生物製藥產品的需求不斷成長。隨著生物技術和製藥業不斷拓展其治療方法組合，尤其是在單株抗體、疫苗和基因治療等領域，監管機構正在實施更嚴格的病毒安全性準則。這種日益嚴格的審查使得對可靠的病毒清除檢驗流程的需求變得迫切，促使企業投資於先進技術和調查方法，以確保病毒清除系統的可靠性和有效性，最終推動市場成長。

限制病毒清除市場的因素

全球病毒清除市場面臨的主要限制因素是病毒清除檢測流程的高成本。這些檢測所需的先進技術和專用設備會增加實驗室和製造商的營運成本。此外，嚴格的監管合規要求以及廣泛的資格確認和檢驗測試進一步推高了成本，為中小企業和Start-Ups企業進入市場設置了財務障礙。同時，漫長的檢測週期會延緩產品開發和市場上市，抑制病毒清除領域的投資和創新，最終阻礙市場成長。

病毒清除市場趨勢

受學名藥和生物相似藥需求不斷成長的推動，病毒清除市場呈現出顯著的發展趨勢，凸顯了全球對經濟有效的慢性病治療方案的迫切需求。這種日益成長的應用也強調了建立健全的病毒清除調查方法的重要性，以確保重組蛋白和其他生物製藥的安全性和有效性。創新技術正被擴大整合到生產流程中，以應對非糖基化蛋白的複雜性，同時提高病毒安全性。隨著醫療機構和監管機構將病患安全置於優先地位，病毒清除解決方案市場預計將大幅擴張，並塑造生物製藥和治療藥物研發的未來。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Charles River Laboratories
Merck KGaA
Texcell
WuXi AppTec
Sartorius AG
Eurofins Scientific
Vironova
Syngene International
Microbac Laboratories
Creative Biolabs
Nelson Labs
SGS AG
Lonza Group
Bioscience Laboratories
Labor Dr. Merk & Kollegen
Gilead Sciences
Poolbeg Pharma
Incyte
Genmab
Biogen

結論與建議

簡介目錄

Product Code: SQMIG35I2288

Viral Clearance Market size was valued at USD 621.83 Billion in 2024 and is poised to grow from USD 721.95 Billion in 2025 to USD 2383.21 Billion by 2033, growing at a CAGR of 16.1% during the forecast period (2026-2033).

Viral clearance is essential for ensuring the safety of products like monoclonal antibodies, recombinant proteins, glycoproteins, and medical devices, as these are susceptible to viral contamination and other impurities. The threat of viruses, bacteria, and fungi can compromise cell culture, raw materials, and bioprocessing stages. Consequently, there is a growing demand for robust viral safety protocols to mitigate these risks. The market for viral clearance is significantly boosted by heightened investments in the pharmaceutical and biotechnology sectors, alongside an increasing need for vaccines and biotherapeutic agents. As the industry focuses on enhancing product safety, the implementation of effective viral clearance methods is becoming a critical component of successful manufacturing practices, driving innovation and growth prospects within this domain.

Top-down and bottom-up approaches were used to estimate and validate the size of the Viral Clearance market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Viral Clearance Market Segments Analysis

Global Viral Clearance Market is segmented by method, application, end-user and region. Based on method, the market is segmented into viral removal method, viral inactivation method and viral detection method. Based on application, the market is segmented into blood and blood products, recombinant proteins, cellular & gene therapy products and vaccines. Based on end-user, the market is segmented into pharmaceutical and biotech industry, academic research institutes and cros. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Viral Clearance Market

A key market driver for the Global Viral Clearance Market is the increasing demand for safe and effective biopharmaceutical products, amid growing concerns regarding the transmission of viruses through biologics. As the biotechnology and pharmaceutical industries expand their portfolios of therapies, particularly in areas like monoclonal antibodies, vaccines, and gene therapies, regulatory bodies are enforcing stricter guidelines for viral safety. This heightened scrutiny prompts an urgent need for robust viral clearance validation processes, spurring investments in advanced technologies and methodologies that ensure the reliability and efficacy of viral clearance systems, ultimately driving market growth.

Restraints in the Viral Clearance Market

A significant market restraint for the Global Viral Clearance Market is the high costs associated with viral clearance testing processes. The sophisticated technology and specialized equipment required for these tests lead to increased operational expenses for laboratories and manufacturers. Additionally, strict regulatory compliance and the need for extensive qualification and validation studies further escalate costs, making it financially challenging for smaller companies and startups to enter the market. Furthermore, the lengthy testing timelines can delay product development and market introduction, which may deter investment and innovation in the viral clearance sector, ultimately hindering market growth.

Market Trends of the Viral Clearance Market

The Viral Clearance market is witnessing a notable trend driven by the rising demand for generics and biosimilars, underscoring the need for cost-effective therapeutic solutions for chronic diseases globally. This surge in adoption emphasizes the necessity for robust viral clearance methodologies to ensure the safety and efficacy of recombinant proteins and other biologics. Innovative technologies are increasingly being integrated into production processes, enhancing viral safety while addressing the complexities of non-glycosylated proteins. As healthcare providers and regulatory bodies prioritize patient safety, the market for viral clearance solutions is expected to expand significantly, shaping the future of biologics and therapeutic development.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement

Global Viral Clearance Market Size by Method & CAGR (2026-2033)

Market Overview
Viral Removal Method
- Chromatography
- Filtration
- Precipitation
Viral Inactivation Method
- Ph Modification
- Solvent Detergent (S/D)
- Pasteurization
- Dry Heat
- Others
Viral Detection Method
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- In Vivo Assay
- In Vitro Assay

Global Viral Clearance Market Size by Application & CAGR (2026-2033)

Market Overview
Blood And Blood Products
Recombinant Proteins
Cellular & Gene Therapy Products
Vaccines

Global Viral Clearance Market Size by End-User & CAGR (2026-2033)

Market Overview
Pharmaceutical And Biotech Industry
Academic Research Institutes
CROs

Global Viral Clearance Market Size & CAGR (2026-2033)

North America (Method, Application, End-User)
- USA
- Canada
Europe (Method, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Method, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Method, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Method, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Texcell
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vironova
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syngene International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microbac Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Biolabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nelson Labs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioscience Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labor Dr. Merk & Kollegen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gilead Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Poolbeg Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Incyte
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genmab
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments